UK Growth Companies With High Insider Ownership To Watch In July 2024

Amidst a backdrop of faltering indices, with the FTSE 100 and FTSE 250 both closing lower due to weak trade data from China, UK markets are navigating through challenging global cues. In such an environment, growth companies with high insider ownership could offer some resilience, as aligned interests between shareholders and management may foster robust strategies to weather economic uncertainties.

Top 10 Growth Companies With High Insider Ownership In The United Kingdom

Name	Insider Ownership	Earnings Growth
Plant Health Care (AIM:PHC)	34.1%	121.3%
Petrofac (LSE:PFC)	16.6%	120.1%
Gulf Keystone Petroleum (LSE:GKP)	12.1%	74.6%
Integrated Diagnostics Holdings (LSE:IDHC)	26.7%	23.5%
Foresight Group Holdings (LSE:FSG)	31.9%	27.9%
Helios Underwriting (AIM:HUW)	23.1%	14.7%
Velocity Composites (AIM:VEL)	27.8%	173.3%
B90 Holdings (AIM:B90)	24.4%	142.7%
Judges Scientific (AIM:JDG)	11.5%	25.3%
Hochschild Mining (LSE:HOC)	38.4%	42.6%

Click here to see the full list of 61 stocks from our Fast Growing UK Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Craneware (AIM:CRW)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Craneware plc, a company that develops, licenses, and supports software for the healthcare industry in the United States, has a market capitalization of approximately £0.86 billion.

Operations: The company generates its revenue primarily from healthcare software, totaling $180.56 million.

Insider Ownership: 17%

Earnings Growth Forecast: 29.4% p.a.

Craneware, a UK-based growth company with high insider ownership, recently enhanced its market position through a strategic partnership with Microsoft. This collaboration involves integrating Craneware's Trisus Platform into the Azure Marketplace, leveraging advanced AI and analytics to boost healthcare operational efficiencies. Despite its moderate revenue growth forecast at 6.7% annually, Craneware's earnings are expected to surge by 29.39% per year, outpacing the UK market significantly. However, its projected Return on Equity remains relatively low at 11.2%.

• Delve into the full analysis future growth report here for a deeper understanding of Craneware.
• Upon reviewing our latest valuation report, Craneware's share price might be too optimistic.

Franchise Brands (AIM:FRAN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Franchise Brands plc operates a franchising business with activities in the United Kingdom, North America, and Europe, and has a market capitalization of approximately £328.70 million.

Operations: The revenue segments for the company are distributed across Azura (£0.75 million), Pirtek (£41.95 million), B2C Division (£6.11 million), Water & Waste (£48.88 million), and Filta International (£27.12 million).

Insider Ownership: 29.8%

Earnings Growth Forecast: 40.7% p.a.

Franchise Brands, a UK growth company with significant insider ownership, is trading 46% below its estimated fair value, indicating potential undervaluation. Analysts expect the stock price to rise by 89.1%, supported by forecasts of robust earnings growth at 40.7% annually, outstripping the UK market's average. However, recent executive turnover and lower profit margins compared to last year suggest some operational challenges despite high revenue projections of £121.27 million for the full year ended December 31, 2023.

• Click here and access our complete growth analysis report to understand the dynamics of Franchise Brands.
• Our valuation report unveils the possibility Franchise Brands' shares may be trading at a discount.

Judges Scientific (AIM:JDG)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Judges Scientific plc is a company that designs, manufactures, and sells scientific instruments, with a market capitalization of approximately £763.75 million.

Operations: The company generates its revenue primarily through two segments: Vacuum, which brings in £63.60 million, and Materials Sciences, contributing £72.50 million.

Insider Ownership: 11.5%

Earnings Growth Forecast: 25.3% p.a.

Judges Scientific, a UK-based company with high insider ownership, has not seen substantial insider buying in the last three months but has experienced more buying than selling overall. The company's earnings are expected to grow by 25.3% annually, outpacing the UK market forecast of 12.6%. Despite a decline in profit margins from 11% to 7% over the past year, revenue growth is projected at 4.8% annually, above the market average of 3.5%. Recent amendments to company bylaws and an approved dividend increase suggest proactive governance and shareholder returns management.

• Click to explore a detailed breakdown of our findings in Judges Scientific's earnings growth report.
• Our comprehensive valuation report raises the possibility that Judges Scientific is priced higher than what may be justified by its financials.

Taking Advantage

• Navigate through the entire inventory of 61 Fast Growing UK Companies With High Insider Ownership here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com